Clinical Outcomes is a product and service business (within Oxford University Innovation) dedicated to the provision and support of high-quality validated outcomes measures (questionnaires) across the healthcare sector. The vast majority of our measures are Patient Reported Outcome (PRO) Measures (or sometimes referred to as PROMs).
We provide licences for some of the most respected and widely deployed outcome measures used by the pharmaceutical industry, healthcare providers, academia and medical device manufacturers.
The Clinical Outcomes team can also provide expert advice on the development and psychometric validation of new COAs and PROs, as well as the use of our own and other health outcome measures.
We’re sponsoring and attending the 10th UK PROMs Research Conference on 23 June 2026 in Sheffield, with registration and calls for abstracts now open!
Oxford University Innovation’s Clinical Outcomes team safeguards the integrity of our Clinical Outcome Assessments during digital migration, ensuring eCOA implementations preserve validity, regulatory alignment and scientific value.
We had the privilege of attending New Horizons 2026, a key UK conference for the Duchenne Muscular Dystrophy (DMD) community.
